𝔖 Bobbio Scriptorium

✦ LIBER ✦

Comparison of three commercial assays for the determination of prothrombin fragment l&2 in healthy subjects and in patients on oral anticoagulant treatment: P. Della Valle, L. Crippa, S. Vigano' D'Angelo E. Pattarini, G. Mazzola, , A. D'Angelo. IRCCS H.S Raffaele, Milano

Book ID: 116086455
Publisher: Elsevier Science
Year: 1993
Tongue: English
Weight: 82 KB
Volume: 70
Category: Article
ISSN: 0049-3848
DOI: 10.1016/0049-3848(93)90293-w

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

In vivo inhibition of prothrombin activa

In vivo inhibition of prothrombin activation follows the reduction of factor ii in the early phase of oral anticoagulant treatment: A. D'Angelo, P. Della Valle, L. Crippa, E. Pattarini, S. Vigano' D'Angelo. IRCCS H.S. Raffaele, Milano

📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 82 KB

Ex vivo evidence that effective inhibiti

Ex vivo evidence that effective inhibition of prothrombin activation follows reduction of plasma factor II in patients starting oral anticoagulant treatment: P. Della Valle, L. Crippa, E. Pattarini, G. Paolillo, A. D'Angelo. Istituto Scientifico I.R.C.C. S. H.S. Raffaele, Milano, Italy

📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 86 KB

Changes of prothrombin fragment 1.2 (f1.

Changes of prothrombin fragment 1.2 (f1.2), thrombin-antithrombin complex (tat) and fibrinopeptide a (fpa) in patients with acute myocardial infarction (ami) treated with thrombolytic agents: L. Crippa, P. Della Valle, S. Gerosa, S. Chierchia, A. D'Angelo. IRCCS H.S. Raffaele, Milano

📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 95 KB